🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

GeneDx Holdings Corp.

WGS Healthcare
$65.5 +$1.28 (1.99%)
Market Cap: $1.92 B
Gurus Holding
5
Popularity Rank
#1908
% of Shares Held
2.64%
Net Activity (Q4 2025)
+$16.18 M

Guru Ownership Trend

Guru Analysis for GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp. (WGS), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $50.62 M.

Top institutional holders include Catherine Wood and Chuck Royce.

Institutional sentiment is currently Bullish. This is evidenced by a $16.18 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Chuck Royce reduced exposure by 26.6%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$27.95 M
Total Buy Value
New Buys 1
Additions 1
-$11.76 M
Total Sell Value
Reductions 3
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
4
Net Buyers
2

FAQs for GeneDx Holdings Corp. (WGS)

Major holders include Catherine Wood ($78.63 M), Chuck Royce ($9.86 M), Renaissance Technologies (RenTech) ($7.45 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 772,833 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $16.18 M, with 2 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited WGS. The total reported sell value was $11.76 M.

Yes, 1 managers opened new positions in WGS, and 1 increased their existing holdings. The total reported buy value was $27.95 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.52% Add 35.3% 604,561 $78.63 M Q4 2025
0.10% Reduce -26.6% 75,783 $9.86 M Q4 2025
0.01% New Buy 57,316 $7.45 M Q4 2025
0.00% Reduce -14.2% 24,673 $3.21 M Q4 2025
0.33% Reduce -16.7% 10,500 $1.37 M Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form